TBRG4 identified as marker of poor survival and driver of tumor progression in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are diagnosed at advanced stages, and five-year survival remains below 20%.